Pages that link to "Q38018841"
Jump to navigation
Jump to search
The following pages link to Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside (Q38018841):
Displaying 26 items.
- Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis (Q26768588) (← links)
- Healing scars: targeting pericytes to treat fibrosis (Q26825838) (← links)
- Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update (Q27027703) (← links)
- A central theory of biology (Q28646894) (← links)
- Nanotechnology applications for the therapy of liver fibrosis (Q33780124) (← links)
- Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells (Q34011505) (← links)
- Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2. (Q34135528) (← links)
- Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction (Q37142522) (← links)
- Update on implications and mechanisms of angiogenesis in liver fibrosis (Q38246718) (← links)
- Strategies to prevent and reverse liver fibrosis in humans and laboratory animals (Q38473640) (← links)
- Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis (Q38684604) (← links)
- Fructose-1,6-bisphosphate reverts iron-induced phenotype of hepatic stellate cells by chelating ferrous ions. (Q38699438) (← links)
- Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling. (Q38972122) (← links)
- Capsaicin modulates proliferation, migration, and activation of hepatic stellate cells. (Q39108646) (← links)
- Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway (Q39669560) (← links)
- Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells (Q41569005) (← links)
- Nanoparticles for the treatment of liver fibrosis (Q42364467) (← links)
- Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α. (Q49196634) (← links)
- Curcumin inhibits aerobic glycolysis in hepatic stellate cells associated with activation of adenosine monophosphate-activated protein kinase. (Q51712676) (← links)
- PPARγ Antagonizes Hypoxia-Induced Activation of Hepatic Stellate Cell through Cross Mediating PI3K/AKT and cGMP/PKG Signaling. (Q52568319) (← links)
- Nogo-B: A potential indicator for hepatic cirrhosis and regulator in hepatic stellate cell activation. (Q53063458) (← links)
- The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach. (Q55270064) (← links)
- Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs. (Q55498732) (← links)
- Therapeutic potential of PPARγ natural agonists in liver diseases (Q89590328) (← links)
- Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways (Q92996195) (← links)
- Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells (Q104459030) (← links)